Return to study ST000393 main page

MB Sample ID: SA018731

Local Sample ID:061215byusa1067_1
Subject ID:SU000414
Subject Type:Animal
Subject Species:Mus musculus
Taxonomy ID:10090
Genotype Strain:C57Bl/6J
Age Or Age Range:4 months
Gender:Female
Human Smoking Status:Former/Current
Animal Animal Supplier:Jackson Laboratories
Animal Housing:housed in a facility at 23°C
Animal Light Cycle:12∶12 hr light cycle, lights on 0700
Animal Feed:with free access to chow (4.5% fat/weight), for at least 1 week before being studied
Species Group:Mammal

Select appropriate tab below to view additional metadata details:


Treatment:

Treatment ID:TR000428
Treatment Summary:Mitochondria (0.6 mg/ml) were supplied with three concentrations of palmitate corresponding to rates of β-oxidation: 1. low (2 µM) 2. medium (9 µM) 3. high (19 µM) Three ml aliquots of incubation medium [IM, (mM): KCl (120), HEPES (5), KH2PO4 (5), MgCl2 (5) and EGTA (1); pH 7.4] were supplemented with (mM) ATP (1), malate (0.05), coenzyme A (0.025), and carnitine (0.5) and added to 20-ml glass reaction vials. Solutions of low, medium and high palmitate concentrations were added to vials in a 6∶1 FA:BSA complex. Two additional incubations were performed as controls: 1. 0 µM palmitate 2. 9 µM palmitate + inhibitors
Treatment Protocol Filename:Long-Chain_Fatty_Acid_Metabolite_Profiles_in_Skeletal_Muscle_Mitochondria.PDF
Treatment Protocol Comments:The first control condition evaluated the metabolic profile of mitochondria oxidizing only malate, and included ATP, carnitine and CoA and ethanol (0.5%). The second control condition assessed effects of FA in the absence of complete oxidative catabolism, and consisted of malate, 9 µM palmitate, ATP, carnitine and CoA, and supplemented with the TCA cycle inhibitor malonate (10 mM) and the electron transport chain complex I inhibitor rotenone (5 µM)
  logo